🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. Cemdisiran

    Regeneron UK Limited

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule terminated

    1 trial

  2. Cemdisiran, Pozelimab

    Lacuna Pharma Pty Ltd

    Paroxysmal nocturnal hemoglobinuria (PNH)

    phase 3 small molecule active

    1 trial

  3. Cemiplimab

    Regeneron UK Limited

    Squamous Cell Carcinoma (SCC)

    phase 3 small molecule completed

    1 trial

  4. Cemiplimab

    Regeneron UK Limited

    Recurrent Lung Non-Small Cell Carcinoma

    phase 3 mab active

    1 trial

  5. Cemiplimab

    Regeneron UK Limited

    Cutaneous Squamous Cell Carcinoma

    phase 3 small molecule active

    7 trials

  6. Cemiplimab

    Regeneron UK Limited

    Cutaneous Squamous Cell Carcinoma (CSCC)

    phase 3 small molecule active

    1 trial

  7. Cendakimab

    Celgene Europe Limited

    Eosinophilic esophagitis

    phase 3 small molecule active

    1 trial

  8. Cenerimod 4 mg, Cenerimod matching placebo

    Viatris Pharmaceuticals Co.,

    Moderate to severe systemic lupus erythematosus

    phase 3 small molecule active

    1 trial

  9. Cenerimod matching placebo, Cenerimod 4 mg

    Viatris Pharmaceuticals Co.,

    Moderate to severe systemic lupus erythematosus

    phase 3 small molecule active

    1 trial

  10. Cenestin 0.3 mg Tablets

    Teva Pharma GmbH

    Hot Flashes

    phase 3 small molecule completed

    1 trial

  11. Cerezyme 400 Units Powder for concentrate for solution for infusion, Placebo 15mg tablets, venglustat GZ402671 - SAR402671, Placebo 6mg tablets, Cerezyme 400 Units Powder for concentrate for solution for infusion, Placebo for Cerezyme, Cerezyme 400 Units Powder for concentrate for solution for infusion, venglustat GZ402671 - SAR402671

    Sanofi-aventis Healthcare Pty Ltd

    Gaucher's disease type III

    phase 3 small molecule active

    1 trial

  12. Cetirizine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    phase 3 small molecule terminated

    1 trial

  13. Cetuximab

    Amgen

    Metastatic Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  14. Champix

    Hospital Authority, Hong Kong

    Tobacco Use Disorder

    phase 3 small molecule completed

    1 trial

  15. Chemotherapy

    The First People's Hospital of Lianyungang

    Acute Lymphoblastic Leukemia

    phase 3 small molecule completed

    1 trial

  16. Chemotherapy + avelumab followed by avelumab + talazoparib

    Pfizer

    Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  17. Chestnut Bloomington Outpatient (CBOP)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  18. Chlorhexidine

    United Therapeutics Europe Ltd

    Infant, Newborn, Diseases

    phase 3 small molecule active

    1 trial

  19. Cholecalciferol

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    phase 3 other completed

    1 trial

  20. Cholic Acid

    Mirum Pharmaceuticals International B.V.

    Bile Acid Synthesis Defect

    phase 3 small molecule completed

    1 trial

  21. Cholic Acids

    Mirum Pharmaceuticals International B.V.

    Infantile Refsum's Disease

    phase 3 small molecule completed

    1 trial

  22. Cholic acid

    Mirum Pharmaceuticals International B.V.

    Inborn Errors of Bile Acid Synthesis

    phase 3 small molecule completed

    1 trial

  23. Chronocort®

    NEUROCRINE BIOSCIENCES INC

    Congenital Adrenal Hyperplasia

    phase 3 small molecule completed

    5 trials

  24. Cibinqo 100 mg film-coated tablets, Placebo for Abrocitinib 100mg tablet

    Pfizer Australia Pty Ltd

    Moderate to severe atopic dermatitis

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources